268 related articles for article (PubMed ID: 21265961)
1. Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?
Santangeli P; Dello Russo A; Casella M; Pelargonio G; Di Biase L; Natale A
Intern Med J; 2011 Jan; 41(1a):55-60. PubMed ID: 21265961
[TBL] [Abstract][Full Text] [Related]
2. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
Buxton AE; Lee KL; Hafley GE; Pires LA; Fisher JD; Gold MR; Josephson ME; Lehmann MH; Prystowsky EN;
J Am Coll Cardiol; 2007 Sep; 50(12):1150-7. PubMed ID: 17868806
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
4. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
[TBL] [Abstract][Full Text] [Related]
5. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
[TBL] [Abstract][Full Text] [Related]
6. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
Lombardi F
Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
[TBL] [Abstract][Full Text] [Related]
7. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
[TBL] [Abstract][Full Text] [Related]
8. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
Dagres N; Hindricks G
Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
11. [Arrhythmia risk stratification in patients with heart failure. Foreword].
Opasich C; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
[TBL] [Abstract][Full Text] [Related]
12. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction.
Hartikainen JE; Malik M; Staunton A; Poloniecki J; Camm AJ
J Am Coll Cardiol; 1996 Aug; 28(2):296-304. PubMed ID: 8800101
[TBL] [Abstract][Full Text] [Related]
13. [Risk stratification and prevention of sudden death in patients with heart failure].
Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
[TBL] [Abstract][Full Text] [Related]
14. Sudden cardiac death and implantable cardioverter-defibrillators.
Turakhia MP
Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
17. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
Saba S
Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
[TBL] [Abstract][Full Text] [Related]
18. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
[TBL] [Abstract][Full Text] [Related]
19. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
Ansalone G; Ricci R; Cacciatore G; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
[TBL] [Abstract][Full Text] [Related]
20. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]